|
|
 |
|
Viewing report
|
|
|
|
Asia: Threat or Opportunity?
Decision Resources, Inc., May 2008, Pages: 40
Introduction
Asian economic might is growing, and the Asian pharmaceutical markets and industry are growing along with it. Western pharmaceutical companies have become very interested in entering Asian markets and taking advantage of the opportunities they offer. Cost cutting alone, however, should not be the sole reason for multinational companies (MNCs) to outsource activities to Southeast Asia. Companies must make the effort to understand the local culture and business environment in each country they want to enter if they are to avoid unrealistic expectations and disappointments. The negative long term effects could overshadow the benefi ts of short-term gains. Although Asian markets may prove challenging, they also offer signifi cant opportunities for companies that focus their needs and then execute well-conceived strategies in specifi c countries.
Get the Answers You Need to Shape Your Strategy
- PricewaterhouseCoopers forecasts that by 2020, the pharmaceutical markets of E7 countries will expand to capture 14% of an $800 billion global market. What are the most important factors and recent activities that are affecting the rise and fall of pharmaceutical importance in Asia? What opportunities does this growth present for Western pharmaceutical companies, and how might this signifi cant growth pose a threat to the same companies?
- There is no “one-size-fi ts-all” approach to doing business in an Asian country. Each company must address its own needs and goals and develop its own strategies. What are the most important short- and longterm implications for branded and generics pharmaceutical companies that want to operate in Asian markets?
- The quality of Chinese-manufactured drugs and the thoroughness of FDA inspections was brought sharply into focus in early 2008 when as many as 81 deaths and hundreds of allergic reactions occurred in people taking Baxter Healthcare’s heparin. What are some of the drawbacks of doing business in Southeast Asia, and what is being done to improve the situation?
- Local Asian companies are moving up the value chain of pharmaceutical drug development. What opportunities are available to them and what types of business alliances are they forming? In the long term, what does the future hold for these companies?
Scope
- Surging growth in Asian economies: a look at the expanding pharmaceutical markets of Asia and the implications that this growth has for global pharmaceutical players.
- Asian pharmaceutical market dynamics: outsourcing activities, emerging markets, and intellectual property landscapes.
- China: market characteristics, growth in API manufacture, and R&D outsourcing activities.
- India: market characteristics, intellectual property issues, growth in API manufacture, R&D outsourcing activities, and recent dealmaking activities.
- Japan: market characteristics and recent areas of growth.
- Coverage of other growing Asian pharmaceutical markets: South Korea, Thailand, Singapore and others.
- Outlook: short- and long-term implications of Asian markets on global pharmaceutical industries.
Customers who bought this item also bought
Indian Pharmaceutical Industry
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
China’s Attraction and Strategies to Work with It: Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
Pharmaceutical Pricing and Reimbursement in India
Understanding the Global Pharmaceutical Market
Contract Research Organization Market- What Pharmaceutical and Biotechnology Companies Want
State of the Pharmaceutical Industry, 2008
The Top 10 Pharmaceutical Companies in India: Growth Strategies, Performance and SWOT Analyses
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
Bio/Pharmaceutical R&D Statistical Sourcebook 2007/2008
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
The Indian Pharmaceutical Industry: Expansion & Ambitions
|
|
|
|
